PTPN22 and autoimmune disease: In summary, our in vivo data provides solid evidence that Pep overexpression can rescue the impaired suppressive function of Blimp-1-deficient Tregs (Fig. 7) and suggests the potential of Pep-mediated TCR signaling inhibition for controlling autoimmune diseases.